Activating endogenous cardiomyocyte proliferation holds great therapeutic promise for cardiac repair. Here, the authors find that RBM22 overcomes the epigenetic obstacles of cardiomyocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results